<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://2medical.news/2026/07/27/colorectal-cancer-incidence-and-mortality-by-age-group-colon-location-and-histology-in-canada/</loc><news:news><news:publication><news:name>2 Medical News</news:name><news:language>en-gb</news:language></news:publication><news:publication_date>2026-07-27T07:00:53+00:00</news:publication_date><news:title>Colorectal cancer incidence and mortality by age group, colon location, and histology in Canada</news:title><news:keywords>cancer, colorectal</news:keywords></news:news></url><url><loc>https://2medical.news/2026/07/26/post-marketing-safety-signals-of-microbiota-based-live-biotherapeutic-products-for-recurrent-clostridioides-difficile-infection-a-faers-pharmacovigilance-study/</loc><news:news><news:publication><news:name>2 Medical News</news:name><news:language>en-gb</news:language></news:publication><news:publication_date>2026-07-26T07:00:44+00:00</news:publication_date><news:title>Post-Marketing Safety Signals of Microbiota-Based Live Biotherapeutic Products for Recurrent Clostridioides difficile Infection: A FAERS Pharmacovigilance Study</news:title><news:keywords>clostridium, microbiota</news:keywords></news:news></url></urlset>